| BCBS Texas Medical Policies | Remdesivir | 2026-07-01 |
| BCBS Texas Medical Policies | Tezepelumab-ekko | 2026-07-01 |
| BCBS Texas Medical Policies | Ustekinumab and Associated Biosimilars | 2026-07-01 |
| BCBS New Mexico Medical Policies | Bioengineered Skin and Soft Tissue Substitutes | 2026-07-01 |
| BCBS New Mexico Medical Policies | Category III Current Procedural Terminology (CPT®) Codes | 2026-07-01 |
| BCBS New Mexico Medical Policies | Depemokimab-ulaa | 2026-07-01 |
| BCBS New Mexico Medical Policies | Efgartigimod alfa-fcab or Efgartigimod alfa and hyaluronidase- | 2026-07-01 |
| BCBS New Mexico Medical Policies | Etuvetidigene autotemcel | 2026-07-01 |
| BCBS New Mexico Medical Policies | Eyelid Thermal Pulsation for the Treatment of Dry Eye | 2026-07-01 |
| UHC Medicare Advantage | Medicare Part B Step Therapy Programs – Medicare Advantage Drug Policy | 2026-07-01 |